Person

Thomas J. Falk

Director, AbbVie

Current S&P 500 boards
2
Current roles
2
Open-market buys
$0
Open-market sales
$81.1M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
May 13, 2019KMBSale11,509$127.23$1.5M
May 13, 2019KMBSale46,709$127.85$6.0M
Apr 24, 2019KMBSale47,814$124.55$6.0M
Apr 24, 2019KMBSale66,937$125.12$8.4M
Apr 23, 2019KMBSale77,610$125.74$9.8M
Apr 23, 2019KMBSale6,217$129.09$803K
Apr 23, 2019KMBSale105,000$126.24$13.3M
Feb 17, 2017KMBSale60,964$131.61$8.0M
Jul 26, 2016KMBSale206,445$133.40$27.5M

SEC reporting-owner ID (CIK) 1222890 · all filings on EDGAR

Thomas J. Falk (ABBV, LMT) | USBoard